Rockefeller Capital Management
TARS icon

Rockefeller Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Rockefeller Capital Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.6K Sell
1,408
-22
-2% -$1.41K ﹤0.01% 3055
2026
Q1 		$100K Buy
1,430
+147
+11% +$10.3K ﹤0.01% 2876
2025
Q4 		$105K Buy
1,283
+172
+15% +$12.8K ﹤0.01% 2703
2025
Q3 		$66K Buy
+1,111
New +$54.7K ﹤0.01% 2772

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Rockefeller Capital Management's TARS Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Tarsus Pharmaceuticals (TARS) stake by 1.5% in Q2 2026, selling an estimated $1.41K and leaving 1,408 shares worth $88.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3055.

Rockefeller Capital Management first reported a position in TARS in Q3 2025 and has held it in 4 quarters since. The position peaked at $105K in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Rockefeller Capital Management held 1,408 shares of Tarsus Pharmaceuticals worth $88.6K as of Q2 2026.
  • Rockefeller Capital Management sold 22 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $1.41K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3055 holding.
  • Rockefeller Capital Management first reported a position in Tarsus Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Rockefeller Capital Management's Tarsus Pharmaceuticals position peaked at $105K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.